发明名称 HYDROLYSIS OF [R(R*,R*)]-2-(4-FLUOROPHENYL)-(3,6-DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4-[(PHENYLAMINO)CARBONYL]-1H-PYRROLE-1-HEPTANOIC ACID ESTERS WITH CALCIUM HYDROXIDE
摘要 The present invention provides a process for preparing atorvastatin hemi-calcium from an atorvastatin ester derivative with calcium hydroxide. The process is conveniently incorporated into a process for preparing atorvastatin hemi-calcium from an acetonide protected, ester protected beta,delta-dihydroxy heptanoic acid precursor compound by a first acid hydrolysis step followed by base hydrolysis with calcium hydroxide. The latter process may be performed as a one-pot process.
申请公布号 HRP20030454(A2) 申请公布日期 2005.10.31
申请号 HR2003P000454 申请日期 2003.06.05
申请人 TEVA PHARMACEUTICAL INDUSTRIES LTD. 发明人 ETI ISHAI;REVITAL LIFSHITZ-LIRON;RAMI LIDOR-HADAS;VALERIE NIDDAM-HILDESHEIM
分类号 A61K9/28;A61K9/50;C07B53/00;C07B61/00;C07D207/34;C07D209/24;C07D213/55;C07D215/14;C07D239/42;C07D403/06;C07D405/06 主分类号 A61K9/28
代理机构 代理人
主权项
地址